Submit Deal

SIXTY DEGREE CAPITAL

HQ - Toronto

Summary

Sixty Degree Capital is a North American venture capital firm specializing in investments in technology and healthcare innovation.

Deals Overview

Total Deals10

Valued Deals10

Total Value£ 979 M

Avg. Deal Size£ 98 M

Market Context

Senior Management

Jian Guo
President
Robert Guo

Sort

antios therapeutics

HQ - United States

Biotechnology

9 Apr 2021

Investment Date

£ 69 M

Deal Value

t-knife

HQ - Germany

Biotechnology

2 Aug 2021

Investment Date

£ 79 M

Deal Value

cincor pharma

HQ - United States

Biotechnology

12 Oct 2021

Investment Date

£ 104 M

Deal Value

korro bio

HQ - United States

Biotechnology

5 Jan 2022

Investment Date

£ 85 M

Deal Value

reflexion medical

HQ - United States

Health Care Services

Medical Equipment

10 Mar 2022

Investment Date

£ 60 M

Deal Value

bionaut labs

HQ - United States

Biotechnology

28 Nov 2022

Investment Date

£ 35 M

Deal Value

frequency therapeutics

HQ - United States

Biotechnology

3 Nov 2023

Investment Date

100%

Stake

£ 129 M

Deal Value

cato networks

HQ - Israel

Software

19 Sep 2023

Investment Date

£ 192 M

Deal Value

fogpharma

HQ - United States

Biotechnology

1 Mar 2024

Investment Date

£ 114 M

Deal Value

aavantgarde bio

HQ - Italy

Biotechnology

3 Nov 2025

Investment Date

£ 105 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy